Published in J Clin Endocrinol Metab on January 01, 1997
Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review. BMC Med (2012) 0.84
Maternal serum and amniotic fluid inhibin A levels in women who subsequently develop severe preeclampsia. J Korean Med Sci (2006) 0.79
Modulation of amniotic fluid activin-a and inhibin-a in women with preterm premature rupture of the membranes and infection-induced preterm birth. Am J Reprod Immunol (2011) 0.78
A Normative Model of Serum Inhibin B in Young Males. PLoS One (2016) 0.77
Umbilical Vein and Maternal Serum Inhibin A, Activin A, and Follistatin Concentrations in IUGR due to Placental Dysfunction Pregnancies. J Obstet Gynaecol India (2013) 0.76
Antenatal modes of surfactant administration for RDS prevention: a review. J Natl Med Assoc (2006) 0.75
Residual debris as a potential cause of postphacoemulsification endophthalmitis. Eye (Lond) (2003) 3.40
Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a systematic review and practice guideline. J Thorac Oncol (2006) 2.66
The oral examination: a study of academic and non-academic factors. Med Educ (1993) 2.65
Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet (1997) 2.22
Communicating prognosis in cancer care: a systematic review of the literature. Ann Oncol (2005) 2.09
First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A. Ann Clin Biochem (1994) 2.06
On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol (1996) 2.03
The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod (2006) 1.93
Localisation of the human ABO: Np-1: AK-1 linkage group by regional assignment of AK-1 to 9q34. Hum Genet (1976) 1.63
Deletion of a DNA sequence in eight of nine families with X-linked ichthyosis (steroid sulphatase deficiency). Nucleic Acids Res (1987) 1.62
Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. J Clin Endocrinol Metab (1996) 1.59
Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females. Clin Endocrinol (Oxf) (2005) 1.57
Second-trimester pregnancy associated plasma protein-A levels are reduced in Cornelia de Lange syndrome pregnancies. Prenat Diagn (1999) 1.55
Acute lymphoblastic leukemia and Klinefelter's syndrome. Pediatr Hematol Oncol (1992) 1.53
Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab (1996) 1.52
Assignment by deletion of human red cell acid phosphatase gene locus to the short arm of chromosome 2. Nat New Biol (1973) 1.49
Meiotic analysis of a pericentric inversion, inv(7) (p22q32), in the father of a child with a duplication-deletion of chromosome 7. Cytogenet Cell Genet (1978) 1.48
Free beta-hCG as first-trimester marker for fetal trisomy. Lancet (1992) 1.47
Measurement of serum concentrations of inhibin-A (alpha-beta A dimer) during human pregnancy. Clin Endocrinol (Oxf) (1995) 1.47
Second-trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay. Prenat Diagn (1993) 1.47
A feasibility study of adolescent sex education: medical students as peer educators in Edinburgh schools. Br J Obstet Gynaecol (1999) 1.46
Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells. Mol Cell Biol (1986) 1.42
Heat-stable and immunoreactive placental alkaline phosphatase in maternal serum from Down's syndrome and trisomy 18 pregnancies. Prenat Diagn (1996) 1.40
Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Clin Endocrinol (Oxf) (1996) 1.40
Placental structure and inflammation in pregnancies associated with obesity. Placenta (2011) 1.39
'Typus edinburgensis' explained. Pediatrics (1991) 1.38
Congenital diaphragmatic defects and maternal serum alphafetoprotein. Am J Med Genet (1988) 1.38
Induction of light chain expression in a pre-B cell line by fusion to myeloma cells. Nature (1981) 1.35
Predictors of ovarian reserve in young women with breast cancer. Br J Cancer (2007) 1.35
Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. J Clin Endocrinol Metab (1997) 1.30
Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels. J Clin Endocrinol Metab (1997) 1.27
Predictive value of amniotic acetylcholinesterase analysis in the diagnosis of fetal abnormality in 3700 pregnancies. Prenat Diagn (1985) 1.25
Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab (1996) 1.20
The oocyte and its role in regulating ovulation rate: a new paradigm in reproductive biology. Reproduction (2004) 1.19
Permanent effects of neonatal estrogen exposure in rats on reproductive hormone levels, Sertoli cell number, and the efficiency of spermatogenesis in adulthood. Endocrinology (1999) 1.19
Phorbol esters enhance spontaneous cytotoxicity of human lymphocytes, abrogate Fc receptor expression, and inhibit antibody-dependent lymphocyte-mediated cytotoxicity. J Immunol (1984) 1.18
Duchenne muscular dystrophy due to familial Xp21 deletion detectable by DNA analysis and flow cytometry. Hum Genet (1986) 1.16
Cytokine secretion by human fetal membranes, decidua and placenta at term. Hum Reprod (1998) 1.16
Preferential expression of variable region heavy chain gene segments by predominant 2,4-dinitrophenyl-specific BALB/c neonatal antibody clonotypes. Proc Natl Acad Sci U S A (1986) 1.13
Structure and biological activities of a heparin-derived hexasaccharide with high affinity for basic fibroblast growth factor. J Biol Chem (1993) 1.13
Expression of oestrogen receptor beta (ERbeta1) protein in human breast cancer biopsies. Br J Cancer (2002) 1.13
Immune response to the src gene product in mice bearing tumors induced by injection of avian sarcoma virus-transformed mouse cells. J Virol (1979) 1.11
Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study. Hum Reprod (1999) 1.08
Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid. J Endocrinol (1996) 1.07
Multipoint linkage analysis of steroid sulfatase (X-linked ichthyosis) and distal Xp markers. Genomics (1987) 1.05
Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein, and age. Prenat Diagn (1991) 1.05
Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. J Clin Endocrinol Metab (1996) 1.04
Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland. J Med Screen (1994) 1.04
Differential expression of estrogen receptor-alpha and -beta and androgen receptor in the ovaries of marmosets and humans. Biol Reprod (2000) 1.03
Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol Appl Neurobiol (1993) 1.01
ICF syndrome (immunodeficiency, centromeric instability and facial anomalies): investigation of heterochromatin abnormalities and review of clinical outcome. Hum Genet (1995) 1.01
Abnormalities in functional development of the Sertoli cells in rats treated neonatally with diethylstilbestrol: a possible role for estrogens in Sertoli cell development. Biol Reprod (1998) 1.01
Physiological relationships between inhibin B, follicle stimulating hormone secretion and spermatogenesis in normal men and response to gonadotrophin suppression by exogenous testosterone. Hum Reprod (1997) 1.00
First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice. Prenat Diagn (2004) 1.00
Development and validation of a new monoclonal antibody to mammalian aromatase. J Endocrinol (2002) 1.00
Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin Endocrinol (Oxf) (1998) 0.98
The inhibition of synthesis of a beta-chemokine, monocyte chemotactic protein-1 (MCP-1) by progesterone. Biochem Biophys Res Commun (1997) 0.97
Age-related changes in the human outflow apparatus. Ophthalmology (1986) 0.97
Regional assignment of nucleoside phosphorylase by exclusion to 14q13. Cytogenet Cell Genet (1978) 0.97
Morquio syndrome: electron microscopic findings. Br J Ophthalmol (2005) 0.96
Cytogenetics in the evaluation of perinatal death. Lancet (1984) 0.96
Maternal and biochemical predictors of antepartum stillbirth among nulliparous women in relation to gestational age of fetal death. BJOG (2007) 0.96
Oocyte-expressed genes affecting ovulation rate. Mol Cell Endocrinol (2005) 0.96
Differing perceptions of intervention thresholds for fracture risk: a survey of patients and doctors. Osteoporos Int (2011) 0.96
Inhibin B levels in plasma of the male rat from birth to adulthood: effect of experimental manipulation of Sertoli cell number. J Androl (1999) 0.95
Tuberous sclerosis: analysis of linkage to red cell and plasma protein markers. Cytogenet Cell Genet (1987) 0.95
Changes in dimeric inhibin A and B during normal early puberty in boys and girls. Clin Endocrinol (Oxf) (1997) 0.95
Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in humanprostate and evidence for formation of new activin heterodimers of beta(C)-subunit. J Clin Endocrinol Metab (2000) 0.94
Full expression of Hunter's disease in a female with an X-chromosome deletion leading to non-random inactivation. Clin Genet (1986) 0.94
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human fetal testis and ovary. Mol Hum Reprod (2001) 0.94
Inhibin B in boys from birth to adulthood: relationship with age, pubertal stage, FSH and testosterone. Clin Endocrinol (Oxf) (2002) 0.94
betaA- and betaC-activin, follistatin, activin receptor mRNA and betaC-activin peptide expression during rat liver regeneration. J Mol Endocrinol (2005) 0.93
Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel. Hum Reprod (1999) 0.92
Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters. Br J Obstet Gynaecol (1997) 0.92
The contribution of chromosome aberrations to the precision of human gene mapping. Cytogenet Cell Genet (1982) 0.92
Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. N Engl J Med (1996) 0.91
Down's syndrome in the Lothian region of Scotland--1978 to 1989. Biomed Pharmacother (1991) 0.91
The importance of multidisciplinary team management of patients with non-small-cell lung cancer. Curr Oncol (2012) 0.91
Relationship between male reproductive hormones, sperm DNA damage and markers of oxidative stress in infertility. Reprod Biomed Online (2007) 0.91
Activin A release into the circulation is an early event in systemic inflammation and precedes the release of follistatin. Endocrinology (2000) 0.90
Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial. Osteoporos Int (2014) 0.90
Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation. Clin Endocrinol (Oxf) (1998) 0.90
Interactions between follicle-stimulating hormone and growth factors in modulating secretion of steroids and inhibin-related peptides by nonluteinized bovine granulosa cells. Biol Reprod (2001) 0.90
Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer. Clin Endocrinol (Oxf) (1996) 0.90
Immunoneutralization of growth differentiation factor 9 reveals it partially accounts for mouse oocyte mitogenic activity. Biol Reprod (2004) 0.90
Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle. J Clin Endocrinol Metab (1998) 0.89
Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome. Hum Reprod (2001) 0.89
Psychosis following acute alteration of thyroid status. Aust N Z J Psychiatry (1997) 0.89
Centromeric linkage. Birth Defects Orig Artic Ser (1975) 0.89
A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancy. Hum Reprod (1998) 0.89
Enzyme-linked immunoadsorbent assays for myelin basic protein and antibodies to myelin basic protein. J Neurochem (1980) 0.89
Role of pemetrexed in advanced non-small-cell lung cancer: meta-analysis of randomized controlled trials, with histology subgroup analysis. Curr Oncol (2012) 0.89
Expression and localization of activin subunits and follistatins in tissues from men with high grade prostate cancer. J Clin Endocrinol Metab (1997) 0.89